NBIX vs VOYG · P/E 45, rev $1.77B vs rev $166.4M
Neurocrine Biosciences Inc (NBIX) versus Voyager Technologies, Inc. (VOYG) — a side-by-side from cached financials, not a winner call.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Voyager Technologies, Inc. (VOYG) is a aerospace & defense company listed on US.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Latest reported VOYG revenue for 2025-12-31 was $166.4M. Net income was -$104.8M. Revenue was up 15.4% from 2024-12-31 to 2025-12-31. VOYG currently screens at market cap $3.25B.
NBIX currently screens at market cap $13.21B and trailing P/E 45.2. VOYG currently screens at market cap $3.25B.
Not investment advice. Open the NBIX and VOYG stock pages for the full models.
Not investment advice.